Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

T Cell Positive B Cell Negative Flow Cytometry Crossmatch (FCXM): Frequency, HLA-Locus Specificity, and Mechanisms Among 3073 Clinical FCXM Tests

Prabhakar Putheti, Vijay K Sharma, Rex Friedlander, Arvind Menon, Darshana Dadhania, Thangamani Muthukumar, Manikkam Suthanthiran
doi: https://doi.org/10.1101/2021.05.20.21257541
Prabhakar Putheti
1Immunogenetics and Transplantation Center, The Rogosin Institute, 430E, 71st Street, New York, NY 10021
2Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, New York Presbyterian-Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: prp9030{at}nyp.org mut9002{at}med.cornell.edu
Vijay K Sharma
1Immunogenetics and Transplantation Center, The Rogosin Institute, 430E, 71st Street, New York, NY 10021
2Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, New York Presbyterian-Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rex Friedlander
1Immunogenetics and Transplantation Center, The Rogosin Institute, 430E, 71st Street, New York, NY 10021
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arvind Menon
1Immunogenetics and Transplantation Center, The Rogosin Institute, 430E, 71st Street, New York, NY 10021
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darshana Dadhania
1Immunogenetics and Transplantation Center, The Rogosin Institute, 430E, 71st Street, New York, NY 10021
2Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, New York Presbyterian-Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065
3Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thangamani Muthukumar
1Immunogenetics and Transplantation Center, The Rogosin Institute, 430E, 71st Street, New York, NY 10021
2Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, New York Presbyterian-Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065
3Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: prp9030{at}nyp.org mut9002{at}med.cornell.edu
Manikkam Suthanthiran
1Immunogenetics and Transplantation Center, The Rogosin Institute, 430E, 71st Street, New York, NY 10021
2Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, New York Presbyterian-Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065
3Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background A T cell positive and B cell negative (T+B-) flow cytometry crossmatch (FCXM) result remains a conundrum since HLA-class I antigens are expressed on both T and B cells. We investigated the frequency, HLA specificity of the antibodies and mechanisms for the T+B- FCXM result.

Methods We analyzed 3073 clinical FCXM tests performed in an American Society of Histocompatibility and Immunogenetics accredited histocompatibility laboratory. The sera associated with the T+B- FCXM were also tested for donor HLA IgG antibodies using LABScreen™ single antigen assays.

Results Among the 3073 FCXM tests, 1963 were T-B-, 811 were T-B+, 274 were T+B+, and 25 were T+B-. IgG antibodies directed at donor HLA-A, B, or Cw locus determined antigens (DSA) were identified in all 25 sera and the summed mean fluorescence intensity (MFI) of DSA ranged from 212 to 53,187. Correlational analyses identified a significant association between the summed MFI of class I DSA, and the median channel fluorescence (MCF) of T cells treated with the recipient serum (Spearman rank correlation, rs=0.34, P=0.05) but not with the MCF of B cells (rs=0.23, P=0.24). We identified that differential binding of anti-HLA antibodies to T cells and B cells and the B cell channel shift threshold used to classify a B cell FCXM are potential contributors to a T+B- FCXM result.

Conclusions Our analysis of 3073 FCXM, in addition to demonstrating that HLA antibodies directed at HLA-A, B or Cw locus are associated with a T+B- result, identified mechanisms for the surprising T+B- FCXM result.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Weill Cornell Medicine Institutional Review Board

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Authorship P.P., V.K.S, and M.S. designed research

  • P.P., V.K.S, R.F., and A.M. performed research

  • T.M., V.K.S., R.F., A.M., D.D, T.M., and M.S. analyzed data

  • P.P. and M.S. wrote the paper

  • Disclosure Manikkam Suthanthiran has a Consultancy Agreement with CareDx, Inc. Brisbane, CA and with Sparks Therapeutics, Philadelphia, PA. The other authors of this manuscript declare no conflicts of interest. The other authors have no disclosures.

  • Funding None

Data Availability

Not applicable

  • ABBREVIATIONS

    ACD
    Acid Citrate Dextrose
    B cell
    B lymphocyte
    CD
    cluster of differentiation
    CDC-XM
    complement dependent cytotoxicity crossmatch
    CS
    channel shift
    DSA
    donor specific antibody
    EDTA
    Ethylenediaminetetraacetic acid
    F(ab’)2
    fragment antigen-binding
    Fc
    fragement crystallizable
    FCXM
    flow cytometry crossmatch
    FITC
    Fluorescein isothiocyanate
    FSC
    forward scatter
    HLA
    human leukocyte antigen
    IgG
    Immunoglobulin G
    IQR
    interquartile range
    LSA
    Luminex single antigen
    mAb
    monoclonal antbody
    MCF
    median channel fluorescence
    MFI
    mean fluorescence intensity
    NCS
    negative control serum
    PBMC
    peripheral blood mononuclear cells
    PBS
    phosphate buffered saline
    PCS
    positive control serum
    PE
    Phycoerythrin
    PerCP
    Peridinin-Chlorophyll-Protein
    RS
    recipient serum
    SSC
    side scatter
    T cell
    T lymphocyte
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted May 24, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    T Cell Positive B Cell Negative Flow Cytometry Crossmatch (FCXM): Frequency, HLA-Locus Specificity, and Mechanisms Among 3073 Clinical FCXM Tests
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    T Cell Positive B Cell Negative Flow Cytometry Crossmatch (FCXM): Frequency, HLA-Locus Specificity, and Mechanisms Among 3073 Clinical FCXM Tests
    Prabhakar Putheti, Vijay K Sharma, Rex Friedlander, Arvind Menon, Darshana Dadhania, Thangamani Muthukumar, Manikkam Suthanthiran
    medRxiv 2021.05.20.21257541; doi: https://doi.org/10.1101/2021.05.20.21257541
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    T Cell Positive B Cell Negative Flow Cytometry Crossmatch (FCXM): Frequency, HLA-Locus Specificity, and Mechanisms Among 3073 Clinical FCXM Tests
    Prabhakar Putheti, Vijay K Sharma, Rex Friedlander, Arvind Menon, Darshana Dadhania, Thangamani Muthukumar, Manikkam Suthanthiran
    medRxiv 2021.05.20.21257541; doi: https://doi.org/10.1101/2021.05.20.21257541

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Transplantation
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)